Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema

Ophthalmology

Volumn 121, Issue 2, 2014, Pages

  Levin, Marc H ^a   Pistilli, Maxwell ^a   Daniel, Ebenezer ^a   Gangaputra, Sapna S ^b   Nussenblatt, Robert B ^c   Rosenbaum, James T ^d   Suhler, Eric B ^d,e   Thorne, Jennifer E ^f   Foster, C Stephen ^g,h   Jabs, Douglas A ^f,i   Levy Clarke, Grace A ^c   Kempen, John H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c NATIONAL EYE INSTITUTE   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e PORTLAND VA MEDICAL CENTER   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g MASSACHUSETTS EYE RESEARCH AND SURGERY INSTITUTION   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTERIOR EYE CHAMBER; ARTICLE; CELL ACTIVITY; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; IRIDOCYCLITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RETINA MACULA EDEMA; RETROSPECTIVE STUDY; RISK FACTOR; UNITED STATES; UVEITIS; VISION; VISUAL ACUITY; VISUAL IMPAIRMENT; VITREOUS BODY;

ADULT; AGED; FEMALE; FLUORESCEIN ANGIOGRAPHY; HLA-B27 ANTIGEN; HUMANS; INCIDENCE; MACULAR EDEMA; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; UVEITIS; VISION, LOW; VISUAL ACUITY; YOUNG ADULT;

EID: 84895068097     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2013.09.023     Document Type: Article

References (31)

1. C.W. Lardenoye, B. van Kooji, and A. Rothova Impact of macular edema on visual acuity in uveitis Ophthalmology 113 2006 1446 1449
2. S.M. Malinowski, J.S. Pulido, and J.C. Folk Long-term visual outcome and complications associated with pars planitis Ophthalmology 100 1993 818 824
3. M. Yanoff, B.S. Fine, A.J. Brucker, and R.C. Eagle Jr. Pathology of human cystoid macular edema Surv Ophthalmol 28 suppl 1984 505 511
4. A. Rothova, M.S. Suttorp-van Schulten, W. Frits Treffers, and A. Kijlstra Causes and frequency of blindness in patients with intraocular inflammatory disease Br J Ophthalmol 80 1996 332 336
5. E.A. Sugar, D.A. Jabs, and M.M. Altaweel et al. Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomography Am J Ophthalmol 152 2011 1044 1052
6. T. Hikichi, and C.L. Trempe Role of the vitreous in the prognosis of peripheral uveitis Am J Ophthalmol 116 1993 401 405
7. J.E. Thorne, E. Daniel, and D.A. Jabs et al. Smoking as a risk factor for cystoid macular edema complicating intermediate uveitis Am J Ophthalmol 145 2008 841 846
8. B. Van Kooij, K. Probst, and R. Fijnheer et al. Risk factors for cystoid macular oedema in patients with uveitis Eye (Lond) 22 2008 256 260
9. N.N. Markomichelakis, I. Halkiadakis, and E. Partelia et al. Course of macular edema in uveitis under medical treatment Ocul Immunol Inflamm 15 2007 71 79
10. O.M. Durrani, N.M. Tehrani, and J.E. Marr et al. Degree, duration, and causes of visual loss in uveitis Br J Ophthalmol 88 2004 1159 1162
11. P.G. Tranos, K.T. Tsaousis, and A.N. Vakalis et al. Long-term follow-up of inflammatory cystoid macular edema Retina 32 2012 1624 1628
12. J.H. Kempen, E. Daniel, and S. Gangaputra et al. Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study Ophthalmic Epidemiol 15 2008 47 55
13. S.R. Taylor, S.L. Lightman, and E.A. Sugar et al. The impact of macular edema on visual function in intermediate, posterior, and panuveitis Ocul Immunol Inflamm 20 2012 171 181
14. T.H. Tran, M.D. de Smet, and B. Bodaghi et al. Uveitic macular oedema: correlation between optical coherence tomography patterns with visual acuity and fluorescein angiography Br J Ophthalmol 92 2008 922 927
15. E. Daniel, M. Pistilli, and S.S. Pujari et al. Risk of hypotony in noninfectious uveitis Ophthalmology 119 2012 2377 2385
16. A. Galor, W. Feuer, and J.H. Kempen et al. Adverse effects of smoking on patients with ocular inflammation Br J Ophthalmol 94 2010 848 853
17. S. Gangaputra, C.W. Newcomb, and T.L. Liesegang et al. Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study. Methotrexate for ocular inflammatory diseases Ophthalmology 116 2009 2188 2198
18. L. Grunwald, C.W. Newcomb, and E. Daniel et al. Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study. Risk of relapse in primary acute anterior uveitis Ophthalmology 118 2011 1911 1915
19. R.O. Kacmaz, J.H. Kempen, and C. Newcomb et al. Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study. Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity Am J Ophthalmol 146 2008 828 836
20. R.O. Kacmaz, J.H. Kempen, and C. Newcomb et al. Cyclosporine for ocular inflammatory diseases Ophthalmology 117 2010 576 584
21. J.H. Kempen, E. Daniel, and J.P. Dunn et al. Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study [report online] BMJ 339 2009 b2480 Available at: http://www.bmj.com/content/339/bmj.b2480?view=long&pmid=19578087 Accessed September 9, 2013
22. S. Pasadhika, J.H. Kempen, and C.W. Newcomb et al. Azathioprine for ocular inflammatory diseases Am J Ophthalmol 148 2009 500 509
23. J.D. Udoetuk, Y. Dai, and G.S. Ying et al. Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Research Group. Risk of corticosteroid-induced hyperglycemia requiring medical therapy among patients with inflammatory eye diseases Ophthalmology 119 2012 1569 1574
24. A. Zaidi, G.S. Ying, and E. Daniel et al. Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Research Group. Hypopyon in patients with uveitis Ophthalmology 117 2010 366 372
25. L.J. Wei, D.Y. Lin, and L. Weissfeld Regression analysis of multivariate incomplete failure time data by using the marginal distribution J Am Stat Assoc 84 1989 1065 1073
26. E. Bloch-Michel, and R. Nussenblatt International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease Am J Ophthalmol 103 1987 234 235
27. Standardization of Uveitis Nomenclature (SUN) Working Group Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop Am J Ophthalmol 140 2005 509 516
28. H.F. Fine, J. Baffi, and G.F. Reed et al. Aqueous humor and plasma vascular endothelial growth factor in uveitis-associated cystoid macular edema Am J Ophthalmol 132 2001 794 796
29. S. Lightman, and J. Greenwood Effect of lymphocytic infiltration of the blood-retinal barrier in experimental autoimmune uveoretinitis Clin Exp Immunol 88 1992 473 477
30. P. Lin, A.R. Loh, T.P. Margolis, and N.R. Acharya Cigarette smoking as a risk factor for uveitis Ophthalmology 117 2010 585 590
31. M. Roesel, A. Ruttig, and C. Schumacher et al. Risk factors for the development of macular edema in noninfectious uveitis Eur J Ophthalmol 21 2011 625 630